Coty (COTY) Q3 2026 [Q&A] earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2026 [Q&A] earnings summary
6 May, 2026Executive summary
Q3 FY26 profit exceeded expectations despite revenue declines and a $362.8M impairment in Consumer Beauty, driven by cost control and investment reallocation to Q4.
The Coty.Curated framework is being implemented to sharpen priorities, focus investments, and improve execution for FY27 and beyond.
Prestige brands remain a core strength, with ongoing launches and market share gains in key markets, while Consumer Beauty improved in the U.S. but lagged in Europe.
Q3 net revenues were $1,281.6M, down 1% reported and 7% LFL year-over-year, with a 1.4% negative impact from the Middle East.
Operating loss widened to $372.0M, primarily due to higher asset impairment charges and increased cost of goods sold.
Financial highlights
Q3 adjusted EBITDA was $127.0M (down 38% YoY); nine-month adjusted EBITDA was $753.3M (down 21%).
Q3 gross margin was 61.8% (down 230 bps YoY), pressured by excess and obsolescence costs, higher manufacturing, and increased promotions.
Adjusted EPS for Q3 was $0.02 (excluding equity swap); 9M26 adjusted EPS was $0.35.
Free cash flow for nine months was $275.6M, up 14% YoY.
Asset impairment charges totaled $362.8M, mainly in Consumer Beauty.
Outlook and guidance
Q4 FY26 LFL revenue expected to decline mid-single digits, with sequential improvement from Q3.
FY26 adjusted EBITDA guidance is $838M–$848M; adjusted EPS (excl. equity swap) expected at $0.33–$0.35.
Q4 adjusted EBITDA expected at $85M–$95M; adjusted EPS (excl. equity swap) breakeven to a loss of $0.02.
Middle East headwinds and COGS pressures expected to persist into Q4 and FY27.
Cost reduction efforts re-accelerated, targeting $80M in FY26 and >$330M by FY27.
Latest events from Coty
- Q3 sales and profit declined amid impairment charges, with cost discipline and transformation ongoing.COTY
Q3 2026 Prepared Remarks6 May 2026 - Q2 FY26 saw stable revenue, margin pressure, and record-low leverage after the Wella divestiture.COTY
Q2 2026 [Q&A]6 Feb 2026 - Q2 saw stable revenue, a net loss from Wella sale, and record-low leverage amid strategic changes.COTY
Q2 2026 Prepared Remarks6 Feb 2026 - Prestige and mass beauty segments grow globally, led by innovation and emerging market expansion.COTY
4th Annual Evercore ISI Consumer & Retail Conference3 Feb 2026 - Double-digit growth, innovation, and global expansion drive strong results and future confidence.COTY
2024 Deutsche Bank dbAccess Global Consumer Conference31 Jan 2026 - Double-digit growth and margin gains outpaced the market, with strong FY25 outlook.COTY
Q4 2024 (Q&A)23 Jan 2026 - Double-digit growth, margin expansion, and strong FY25 outlook driven by innovation and global reach.COTY
Q4 2024 Prepared Remarks23 Jan 2026 - Prestige and mass fragrances drove Q1 growth, with margin expansion and strong emerging market gains.COTY
Q1 2025 Prepared Remarks16 Jan 2026 - Prestige fragrance growth and margin gains drove Q1 outperformance and a positive FY25 outlook.COTY
Q1 2025 (Q&A)15 Jan 2026